Last reviewed · How we verify
NCT05781828
Noninvasive Methods For Prediction of Esophageal Varices in Children
trial testing Detailed abdominal ultrasound in Esophageal Varices in 30 participants. Status unknown.
1 August 2023
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 15 March 2023 |
| Primary completion | 1 August 2023 |
| Estimated completion | 1 September 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Detailed abdominal ultrasound
Conditions studied
- Esophageal Varices — all drugs for Esophageal Varices →
Sponsor
Assiut University
Who can join
Adults 1 Day to 18, any sex, with Esophageal Varices. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to use non-invasive methods to identify patients at risk of developing gastrointestinal varices and correlation of these non-invasive methods with the degree of esophageal varices and the presence or absence of risk signs of bleeding such as cherry red spots.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05781828
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Esophageal Varices
Currently open trials in the same condition.
- NCT07122622 — 2D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices · recruiting
- NCT06881082 — Cross-section Band Ligation Versus Stepladder Band Ligation of Esophageal Varices · NA · recruiting
- NCT05979935 — A Digital Tongue Diagnosis Model for High- and Low-risk Esophagogastroduodenal Varices in Cirrhosis · active not recruiting
- NCT04499898 — Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding · Phase 2, PHASE3 · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05781828 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 18 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05781828.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing